In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease
Clinical trial NCT05974345 · COMPLETED
Trial details
- NCT number
- NCT05974345
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-03
- Primary completion
- 2023-12-15
- Enrollment
- 204691
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.